Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway

Fig. 6

Wogonin inhibited tumor growth in a xenografts mouse model. a The BALB/c nude mice were injected with Raji cells for a few days followed by treatment with solvent or various doses of wogonin every other day for 14 days. Then, the mice were killed, tumor removed and photographed. b, c, d The tumor size, tumor weight and body weight measurements. Bars are shown as mean ± SD (n = 5). The comparisons were made relative to untreated controls, and the difference level of significance was indicated as (*P < 0.05)

Back to article page